Cytochrome P450 and anticancer drugs

Current Drug Metabolism

Volumn 7, Issue 1, 2006, Pages 23-37

  Fujita, Ken Ichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anticancer drugs; Chemotherapy; CYP; Individualized medicine; Interindividual variation

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; AZ 1839; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOCHROME P450; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; DOCETAXEL; ERYTHROMYCIN; ETOPOSIDE; GEFITINIB; HYDROCORTISONE; IFOSFAMIDE; IMATINIB; MIDAZOLAM; NAVELBINE; PACLITAXEL; TAMOXIFEN; TEGAFUR; TENIPOSIDE; THALIDOMIDE; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; VINDESINE; ISOENZYME;

AFRICAN AMERICAN; AGING; AREA UNDER THE CURVE; ASIAN; CANCER THERAPY; CAUCASIAN; CHINESE; CIGARETTE SMOKING; CYTOTOXICITY; DEMETHYLATION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG HYDROXYLATION; DRUG MECHANISM; DRUG METABOLISM; DRUG TRANSFORMATION; DRUG UTILIZATION; ENDOMETRIUM CANCER; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; FOOD INTAKE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEALTH STATUS; HUMAN; IN VIVO STUDY; INDIVIDUALIZATION; LIVER PARENCHYMA; MALIGNANT NEOPLASTIC DISEASE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PATIENT CARE; PHENOTYPE; PROTEIN EXPRESSION; RACE DIFFERENCE; RAT; REVIEW; SMALL INTESTINE; TERATOGENESIS; WILD TYPE; ANIMAL; GENETICS; METABOLISM;

ANIMALS; ANTINEOPLASTIC AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; GENE FREQUENCY; HUMANS; ISOENZYMES;

EID: 33644866971     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920006774832587     Document Type: Review

References (175)

1. Wilkinson, G.R. (2005) N. Engl. J. Med., 352(21),2211-2221.
2. Rochat, B. (2005) Clin. Pharmacokinet., 44(4), 349-366.
3. Nelson, D.R.; Koymans, L.; Kamataki, T.; Stegeman, J.J.; Feyereisen, R.; Waxman, D.J.; Waterman, M.R.; Gotoh, O.; Coon, M.J.; Estabrook, R.W.; Gunsalus, I.C. and Nebert, D.W. (1996) Pharmacogenetics, 6(1), 1-42.
4. Evans, W.E. and Relling, M.V. (2004) Nature, 429(6990), 464-468.
5. Evans, W.E. and McLeod, H.L. (2003) N. Engl. J. Med., 348(6), 538-549.
6. Cresteil, T.; Monsarrat, B.; Alvinerie, P.; Treluyer, J.M.; Vieira, I. and Wright, M. (1994) Cancer Res., 54(2), 386-392.
7. Monsarrat, B.; Mariel, E.; Cros, S.; Gates, M.; Guenard, D.; Gueritte-Voegelein, F. and Wright, M. (1990) Drug Metab. Dispos., 18(6), 895-901.
8. Eddershaw, P.J. and Dickins, M. (1999) Pharm. Sci. Technol. Today, 2(1), 13-19.
9. Ekins, S.; Ring, B.J.; Grace, J.; McRobie-Belle, D.J. and Wrighton, S.A. (2000) J. Pharmacol. Toxicol Methods, 44(1), 313-324.
10. LeCluyse, E.L. (2001) Eur. J. Pharm. Sci., 13(4), 343-368.
11. Li, A.P.; Gorycki, P.D.; Hengstler, J.G.; Kedderis, G.L.; Koebe, H.G.; Rahmani, R.; de Sousas, G.; Silva, J.M. and Skett, P. (1999) Chem. Biol. Interact., 121(1), 117-123.
12. Rodrigues, A.D. (1994) Biochem. Pharmacol., 48(12), 2147-2156.
13. Streetman, D.S.; Bertino, J.S. and Nafziger, A.N. (2000) Pharmacogenetics, 10(3), 187-216.
14. Venkatakrishnan, K.; von Moltke, L.L.; Obach, R.S. and Greenblatt, D.J. (2003) Curr. Drug Metab., 4(5), 423-459.
15. Venkatakrishnan, K.; von Moltke, L.L. and Greenblatt, D.J. (2001) J. Clin. Pharmacol., 41(11), 1149-1179.
16. Iwata, H.; Fujita, K.; Kushida, H.; Suzuki, A.; Konno, Y.; Nakamura, K.; Fujino, A. and Kamataki, T. (1998) Biochem. Pharmacol., 55(8), 1315-1325.
17. Fujita, K.; Nakayama, K.; Yamazaki, Y.; Tsuruma, K.; Yamada, M.; Nohmi, T. and Kamataki, T. (2001) Environ. Mol. Mutagen., 38(4), 329-338.
18. Fujita, K. and Kamataki, T. (2002) Drug Metab. Pharmacokin., 17(1), 1-22.
19. Stahelin, H.F. and von Wartburg, A. (1991) Cancer Res., 51(1), 5-15.
20. Clark, P.I. and Slevin, M.L. (1987) Clin. Pharmacokinet., 12(4), 223-252.
21. Relling, M.V.; Nemec, J.; Schuetz, E.G.; Schuetz, J.D.; Gonzalez, F.J. and Korzekwa, K.R. (1994) Mol. Pharmacol., 45(2), 352-358.
22. Kawashiro, T.; Yamashita, K.; Zhao, X.J.; Koyama, E.; Tani, M.; Chiba, K. and Ishizaki, T. (1998) J. Pharmacol. Exp. Ther., 286(3), 1294-1300.
23. Zhao, X.J.; Kawashiro, T. and Ishizaki, T. (1998) Drug Metab. Dispos., 26(2), 188-191.
24. Buchdunger, E.; Zimmermann, J.; Mett, H.; Meyer, T.; Muller, M.; Druker, B.J. and Lydon, N.B. (1996) Cancer Res., 56(1), 100-104.
25. Druker, B.J.; Tamura, S.; Buchdunger, E.; Ohno, S.; Segal, G.M.; Fanning, S.; Zimmermann, J. and Lydon N.B. (1996) Nat. Med., 2(5), 561-566.
26. Buchdunger, E.; Cioffi, C.L.; Law, N.; Stover, D.; Ohno-Jones, S.; Druker, B.J. and Lydon, N.B. (2000) J. Pharmacol. Exp. Ther., 295(1), 139-145.
27. Heinrich, M.C.; Griffith, D.J.; Druker, B.J.; Wait, C.L.; Ott, K.A. and Zigler, A.J. (2000) Blood, 96(3), 925-932.
28. Druker, B.J.; Sawyers, C.L.; Kantarjian, H.; Resta, D.J.; Reese, S.F.; Ford, J.M.; Capdeville, R. and Talpaz, M. (2001) N. Engl. J. Med., 344(14), 1038-1042.
29. Druker, B.J.; Talpaz, M.; Resta, D.J.; Peng, B.; Buchdunger, E.; Ford, J.M.; Lydon, N.B.; Kantarjian, H.; Capdeville, R.; Ohno-Jones, S. and Sawyers, C.L. (2001) N. Engl. J. Med., 344(14), 1031-1037.
30. Talpaz, M.; Silver, R.T.; Druker, B.J.; Goldman, J.M.; Gambacorti-Passerini, C.; Guilhot, F.; Schiffer, C.A.; Fischer, T.; Deininger, M.W.; Lennard, A.L.; Hochhaus, A.; Ottmann, O.G.; Gratwohl, A.; Baccarani, M.; Stone, R.; Tura, S.; Mahon, F.X.; Fernandes-Reese, S.; Gathmann, I.; Capdeville, R.; Kantarjian, H.M. and Sawyers, C.L. (2002) Blood, 99(6), 1928-1937.
31. Kantarjian, H.; Sawyers, C.; Hochhaus, A.; Guilhot, F.; Schiffer, C.; Gambacorti-Passerini, C.; Niederwieser, D.; Resta, D.; Capdeville, R.; Zoellner, U.; Talpaz, M.; Druker, B.; Goldman, J.; O'Brien, S.G.; Russell, N.; Fischer, T.; Ottmann, O.; Cony-Makhoul, P.; Facon, T.; Stone, R.; Miller, C.; Tallman, M.; Brown, R.; Schuster, M.; Loughran, T.; Gratwohl, A.; Mandelli, F.; Saglio, G.; Lazzarino, M.; Russo, D.; Baccarani, M.; Morram, E. and International STI571 CML Study Group. (2002) N. Engl. J. Med., 346(9), 645-652.
32. O'Brien, S.G.; Guilhot, F.; Larson, R.A.; Gathmann, I.; Baccarani, M.; Cervantes, F.; Cornelissen, J.J.; Fischer, T.; Hochhaus, A.; Hughes, T.; Lechner, K.; Nielsen, J.L.; Rousselot, P.; Reiffers, J.; Saglio, G.; Shepherd, J.; Simonsson, B.; Gratwohl, A.; Goldman, J.M.; Kantarjian, H.; Taylor, K.; Verhoef, G.; Bolton, A.E.; Capdeville, R.; Druker, B.J. and IRIS Investigators. (2003) N. Engl. J. Med., 348(11), 994-1004.
33. Joensuu, H.; Roberts, P.J.; Sarlomo-Rikala, M.; Anderson, L.C.; Tervahartiala, P.; Tuveson, D.; Silberman, S.; Capdeville, R.; Dimitrijevic, S.; Druker, B. and Demetri, G.D. (2001) N. Engl. J. Med., 344(14), 1052-1056.
34. Cohen, M.H.; Williams, G.A.; Sridhara, R.; Chen, G.; McGuinn, W.D. Jr; Morse, D.; Abraham, S.; Rahman, A.; Liang, C.; Lostritto, R.; Baird, A. and Pazdur, R. (2004) Clin. Cancer Res., 10(4), 1212-1218.
35. McKillop, D.; McCormick, A.D.; Millar, A.; Miles, G.S.; Phillips, P.J. and Hutchison, M. (2005) Xenobiotica, 35(1), 39-50.
36. Sladek, N.E. (1994) In Anticancer Drugs: Reactive Metabolism and Drug Interactions (Powis, G. ed.), Pergamon Press, New York, pp. 79-156.
37. Colvin, M.; Padgett, C.A. and Fenselau, C. (1973) Cancer Res., 33(4), 915-918.
38. Connors, T.A.; Cox, P.J.; Farmer, P.B.; Foster, A.B. and Jarman, M. (1974) Biochem. Pharmacol., 23(1), 115-129.
39. Struck, R.F.; Kirk, M.C.; Witt, M.H. and Laster, W.R. Jr. (1975) Blamed. Mass. Spectrom., 2(1), 46-52.
40. Walker, D.; Flinois, J.P.; Monkman, S.C.; Beloc, C.; Boddy, A.V.; Cholerton, S.; Daly, A.K.; Lind, M.J.; Pearson, A.D. and Beaune, P.H. (1994) Biochem. Pharmacol., 47(7), 1157-1163.
41. Chang, T.K.; Weber, G.F.; Crespi, C.L. and Waxman, D.J. (1993) Cancer Res., 53(23), 5629-5637.
42. Ren, S.; Yang, J.S.; Kalhorn, T.F. and Slattery, J.T. (1997) Cancer Res., 57(19), 4229-4235.
43. Huang, Z.; Roy, P. and Waxman, D.J. (2000) Biochem. Pharmacol., 59(8), 961-972.
44. Kaijser, G.P.; Korst, A.; Beijnen, J.H.; Bult, A. and Underberg, W.J. (1993) Anticancer Res., 13(5A), 1311-1324.
45. Fleming, R.A. (1997) Pharmacotherapy, 17(5 Pt 2), 146S-154S.
46. Roy, P.; Tretyakov, O.; Wright, J. and Waxman, D.J. (1999) Drug Metab. Dispos., 27(11), 1309-1318.
47. Osborne, C.K. (1998) N. Engl. J. Med., 339(22), 1609-1618.
48. Fisher, B.; Costantino, J.P.; Wickerham, D.L.; Redmond, C.K.; Kavansh, M.; Cronin, W.M.; Vogel, V.; Robidoux, A.; Dimitrov, N.; Atkins, J.; Daly, M.; Wieand, S.; Tan-Chiu, E.; Ford, L. and Wolmark, N. (1998) J. Natl. Cancer Inst., 90(18), 1371-1388.
49. Jordan, V.C.; Collins, M.M.; Rowsby, L. and Prestwich, G. (1977) J. Endocrinol., 75(2), 305-316.
50. Fabian, C.; Tilzer, L. and Sternson, L. (1981) Biopharm. Drug. Dispos., 2(4), 381-390.
51. Stearns, V.; Johnson, M.D.; Rae, J.M.; Morocho, A.; Novielli, A.; Bhargava, P.; Hayes, D.F.; Desta, Z. and Flockhart, D.A. (2003) J. Natl. Cancer Inst., 95(23), 1758-1764.
52. Crewe, H.K.; Ellis, S.W.; Leonard, M.S. and Tucker, G.T. (1997) Biochem. Pharmacol., 53(2), 171-178.
53. Desta, Z.; Ward, B.A.; Soukhova, N.V. and Flockhart, D.A. (2004) J. Pharmacol. Exp. Ther., 310(3), 1062-1075.
54. Swerdlow, A.J.; Jones, M.E. and British Tamoxifen Second Cancer Study Group. (2005) J. Nat. Cancer Inst., 97(5), 375-384.
55. Shibutani, S.; Dasaradhi, L.; Terashima, I.; Banoglu, E. and Duffel, M.W. (1998) Cancer Res., 58(4), 647-653.
56. Shibutani, S.; Ravindernath, A.; Suzuki, N.; Terashima, I.; Sugarman, S.M.; Grollman, A.P. and Pearl, M.L. (2000) Carcinogenesis, 21(8), 1461-1467.
57. Kim, S.Y.; Suzuki, N.; Santosh, Laxmi, Y.R.; Rieger, R. and Shibutani, S. (2003) Chem. Res. Toxicol., 16(9), 1138-1144.
58. Kim, S.Y.; Suzuki, N.; Laxmi, Y.R.; McGarrigle, B.P.; Olson, J.R.; Sharma, M.; Sharma, M. and Shibutani, S. (2005) Chem. Res. Toxicol., 18(5), 889-895.
59. Rowinsky, E.K. (1997) Annu. Rev. Med., 48, 353-374.
60. Monsarrat, B.; Alvinerie, P.; Wright, M.; Dubois, J.; Gueritte-Voegelein, F.; Guenard, D.; Donehower, R.C. and Rowinsky, E.K. (1993) J. Natl. Cancer Inst. Monogr., 15, 39-46.
61. Monsarrat, B.; Wright, M.; Dubois, J.; Gueritte-Voegelein, F.; Guenard, D.; Rowinsky, E.K. and Donehower, R.C. (1992) Ann. Oncol., 3(Suppl. 1), 123.
62. Rahman, A.; Korzekwa, K.R.; Grogan, J.; Gonzalez, F.J. and Harris, J.W. (1994) Cancer Res., 54(21), 5543-5546.
63. Royer, I.; Monsarrat, B.; Sonnier, M.; Wright, M. and Cresteil, T. (1996) Cancer Res., 56(1), 58-65.
64. Richardson, P.; Hideshima, T. and Anderson, K. (2002) Annu. Rev. Med., 53, 629-657.
65. D'Amato, R.J.; Loughnan, M.S.; Flynn, E. and Folkman, J. (1994) Proc. Natl. Acad. Sci. USA, 91(9), 4082-4085.
66. Figg, W.D.; Dahut, W.; Duray, P.; Hamilton, M.; Tompkins, A.; Steinberg, S.M.; Jones, E.; Premkumar, A.; Linehan, W.M.; Floeter, M.K.; Chen, C.C.; Dixon, S.; Kohler, D.R.; Kruger, E.A.; Gubish, E.; Pluda, J.M. and Reed, E. (2001) Clin. Cancer Res., 7(7), 1888-1893.
67. Singhal, S.; Mehta, J.; Desikan, R.; Ayers, D.; Roberson, P.; Eddlemon, P.; Munshi, N.; Anaissie, E.; Wilson, C.; Dhodapkar, M.; Zeddis, J. and Barlogie, B. (1999) N. Engl. J. Med., 341(21), 1565-1571.
68. Braun, A.G.; Harding, F.A. and Weinreb, S.L. (1986) Toxicol. Appl. Pharmacol., 82(1), 175-179.
69. Bauer, K.S.; Dixon, S.C. and Figg, W.D. (1998) Biochem. Pharmacol., 55(11), 1827-1834.
70. Braun, A.G. and Weinreb, S.L. (1985) Teratog. Carcinog. Mutagen., 5(3), 149-158.
71. Eriksson, T.; Bjorkman, S.; Roth, B.; Bjork, H. and Hoglund, P. (1998) J. Pharm. Pharmacol., 50(12), 1409-1416.
72. Teo, S.K.; Sabourin, P.J.; O'Brien, K.; Kook, K.A. and Thomas, S.D. (2000) J. Biochem. Mol. Toxicol., 14(3), 140-147.
73. Ando, Y.; Fuse, E. and Figg, W.D. (2002) Clin. Cancer Res., 8(6), 1964-1973.
74. Ikeda, K.; Yoshisue, K.; Matsushima, E.; Nagayama, S.; Kobayashi, K.; Tyson, C.A.; Chiba, K. and Kawaguchi, Y. (2000) Clin. Cancer Res., 6(11), 4409-4415.
75. Zhou-Pan, X.R.; Seree, E.; Zhou, X.J.; Placidi, M.; Maurel, P.; Barra, Y. and Rahmani, R. (1993) Cancer Res., 53(21), 5121-5126.
76. Zhou, X.J.; Zhou-Pan, X.R.; Gauthier, T.; Placidi, M.; Maurel, P. and Rahmani, R. (1993) Biochem. Pharmacol., 45(4), 853-861.
77. Kajita, J.; Kuwabara, T.; Kobayashi, H. and Kobayashi, S. (2000) Drug Metab. Dispos., 28(9), 1121-1127.
78. Baker, S.D.; Verweij, J.; Rowinsky, E.K.; Donehower, R.C.; Schellens, J.H.; Grochow, L.B. and Sparreboom, A. (2002) J. Natl. Cancer Inst., 94(24), 1883-1888.
79. Ando, Y.; Ohtsu, T.; Ando, M.; Ohyanagi, F.; Nagashima, F.; Narabayashi, M.; Saijo, N. and Sasaki, Y. (2003) J. Natl. Cancer Inst., 95(21), 1638-1640.
80. Phillips, K.A.; Veenstra, D.L.; Oren, E.; Lee, J.K. and Sadee, W. (2001) JAMA, 286(18), 2270-2279.
81. Daigo, S.; Takahashi, Y.; Fujieda, M.; Ariyoshi, N.; Yamazaki, H.; Koizumi, W.; Tanabe, S.; Saigenji, K.; Nagayama, S.; Ikeda, K.; Nishioka, Y. and Kamataki T. (2002) Pharmacogenetics, 12(4), 299-306.
82. Nunoya, K.; Yokoi, T.; Kimura, K.; Inoue, K.; Kodama, T.; Funayama, M.; Nagashima, K.; Funae, Y.; Green, C.; Kinoshita, M. and Kamataki, T. (1998) Pharmacogenetics, 8(3), 239-249.
83. Komatsu, T.; Yamazaki, H.; Shimada, N.; Nagayama, S.; Kawaguchi, Y.; Nakajima, M. and Yokoi, T. (2001) Clin. Cancer Res., 7(3), 675-681.
84. Nakajima, M.; Yoshida, R.; Fukami, T.; McLeod, H.L. and Yokoi, T. (2004) FEBS Lett., 569(1-3), 75-81.
85. Schoedel, K.A.; Hoffmann, E.B.; Rao, Y.; Sellers, E.M. and Tyndale, R.F. (2004) Pharmacogenetics, 14(9), 615-626.
86. Kiyotani, K.; Fujieda, M.; Yamazaki, H.; Shimada, T.; Guengerich, F.P.; Parkinson, A.; Nakagawa, K.; Ishizaki, T. and Kamataki, T. (2002) Drug Metab. Pharmacokinet., 17(5), 482-487.
87. Fukami, T.; Nakajima, M.; Higashi, E.; Yamanaka, H.; Sakai, H.; McLeod, H.L. and Yokoi, T. (2005) Drug Metab. Dispos., 33(8), 1202-1210.
88. Fukami, T.; Nakajima, M.; Yoshida, R.; Tsuchiya, Y.; Fujiki, Y.; Katoh, M.; McLeod, H.L. and Yokoi, T. (2004) Clin. Pharmacol. Ther., 76(6), 519-527.
89. Fukami, T.; Nakajima, M.; Higashi, E.; Yamanaka, H.; McLeod, H.L. and Yokoi, T. (2005) Biochem. Pharmacol., 70(5), 801-808.
90. Yoshida, R.; Nakajima, M.; Watanabe, Y.; Kwon, J.T. and Yokoi, T. (2002) Br. J. Clin. Pharmacol., 54(5), 511-517.
91. Oscarson, M.; McLellan, R.A.; Gullsten, H.; Agundez, J.A.; Benitez, J.; Rautio, A.; Raunio, H.; Pelkonen, O. and Ingelman-Sundberg, M. (1999) FEBS Lett., 460(2), 321-327.
92. Ariyoshi, N.; Takahashi, Y.; Miyamoto, M.; Umetsu, Y.; Daigo, S.; Tateishi, T.; Kobayashi, S.; Mizorogi, Y.; Loriot, M.A.; Stucker, I.; Beaune, P.; Kinoshita, M. and Kamataki, T. (2000) Pharmacogenetics, 10(8), 687-693.
93. Ariyoshi, N.; Sekine, H.; Nakayama, K.; Saito, K.; Miyamoto, A. and Kamataki, T. (2004) Pharmacogenetics, 14(10), 701-705.
94. Caraco, Y. (2004) N. Engl. J. Med., 351(27), 2867-2869.
95. Jin, Y.; Desta, Z.; Stearns, V.; Ward, B.; Ho, H.; Lee, KH.; Skaar, T.; Storniolo, A.M.; Li, L.; Araba, A.; Blanchard, R.; Nguyen, A.; Ullmer, L.; Hayden, J.; Lemler, S.; Weinshilboum, R.M.; Rae, J.M.; Hayes, D.F. and Flockhart, D.A. (2005) J. Natl. Cancer Inst., 97(1), 30-39.
96. Sachse, C.; Brockmoller, J.; Bauer, S. and Roots, I. (1997) Am. J. Hum. Genet., 60(2), 284-295.
97. Marez, D.; Legrand, M.; Sabbagh, N.; Guidice, J.M.; Spire, C.; Lafitte, J.J.; Meyer, U.A. and Broly, F. (1997) Pharmacogenetics, 7(3), 193-202.
98. Kubota, T.; Yamaura, Y.; Ohkawa, N.; Hara, H. and Chiba, K. (2000) Br. J. Clin. Pharmacol., 50(1), 31-34.
99. McLellan, R.A.; Oscarson, M.; Seidegard, J.; Evans, D.A. and Ingelman-Sundberg, M. (1997) Pharmacogenetics, 7(3), 187-191.
100. Gaikovitch, E.A.; Cascorbi, I.; Mrozikiewicz, P.M.; Brockmoller, J.; Frotschl, R.; Kopke, K.; Gerloff, T.; Chernov, J.N. and Roots, I. (2003) Eur. J. Clin. Pharmacol., 59(4), 303-312.
101. Tateishi, T.; Chida, M.; Ariyoshi, N.; Mizorogi, Y.; Kamataki, T. and Kobayashi, S. (1999) Clin. Pharmacol. Ther., 65(5), 570-575.
102. Nishida, Y.; Fukuda, T.; Yamamoto, I. and Azuma, J. (2000) Pharmacogenetics, 10(6), 567-570.
103. Johansson, I.; Oscarson, M.; Yue, Q.Y.; Bertilsson, L.; Sjoqvist, F. and Ingelman-Sundberg, M. (1994) Mol. Pharmacol., 46(3), 452-459.
104. Aklillu, E.; Persson, I.; Bertilsson, L.; Johansson, I.; Rodrigues, F. and Ingelman-Sundberg, M. (1996) J. Pharmacol. Exp. Ther., 278(1), 441-446.
105. de Wildt, S.N.; Kearns, G.L.; Leeder, J.S. and van den Anker, J.N. (1999) Clin. Pharmacokinet., 37(6), 485-505.
106. Koch, I.; Weil, R.; Wolbold, R.; Brockmoller, J.; Hustert, E.; Burk, O.; Nuessler, A.; Neuhaus, P.; Eichelbaum, M.; Zanger, U. and Wojnowski, L. (2002) Drug Metab. Dispos., 30(10), 1108-1114.
107. Williams, J.A.; Ring, B.J.; Cantrell, V.E.; Jones, D.R.; Eckstein, J.; Ruterbories, K.; Hamman, M.A.; Hall, S.D. and Wrighton, S.A. (2002) Drug Metab. Dispos., 30(8), 883-891.
108. Lamba, J.K.; Lin, Y.S.; Schuetz, E.G. and Thummel, K.E. (2002) Adv. Drug Deliv. Rev., 54(10), 1271-1294.
109. Amirimani, B.; Walker, A.H.; Weber, B.L. and Rebbeck, T.R. (1999) J. Natl. Cancer Inst., 91(18), 1588-1590.
110. Ando, Y.; Tateishi, T.; Sekido, Y.; Yamamoto, T.; Satoh, T.; Hasegawa, Y.; Kobayashi, S.; Katsumata, Y.; Shimokata, K. and Saito, H. (1999) J. Nat. Cancer Inst., 91(18), 1587-1590.
111. Rebbeck, T.R.; Jaffe, J.M.; Walker, A.H.; Wein, A.J. and Malkowicz, S.B. (1998) J. Nat. Cancer Inst., 90(16), 1225-1229.
112. Felix, C.A.; Walker, A.H.; Lange, B.J.; Williams, T.M.; Winick, N.J.; Cheung, N.K.; Lovett, B.D.; Nowell, P.C.; Blair, I.A. and Rebbeck, T.R. (1998) Proc. Natl. Acad. Sci. USA, 95(22), 13176-13181.
113. Wandel, C.; Witte, J.S.; Hall, J.M.; Stein, C.M.; Wood, A.J. and Wilkinson, G.R. (2000) Clin. Pharmacol. Ther., 68(1), 82-91.
114. Floyd, M.D.; Gervasini, G.; Masica, A.L.; Mayo, G.; George, A.L. Jr.; Bhat, K.; Kim, R.B. and Wilkinson, G.R. (2003) Pharmacogenetics, 13(10), 595-606.
115. Eap, C.B.; Buclin, T.; Hustert, E.; Bleiber, G.; Golay, K.P.; Aubert, A.C.; Baumann, P.; Telenti, A. and Kerb, R. (2004) Eur. J. Clin. Pharmacol., 60(4), 231-236.
116. Baker, S.D.; van Schaik, R.H.; Rivory, L.P.; Ten Tije, A.J.; Dinh, K.; Graveland, W.J.; Schenk, P.W.; Charles, K.A.; Clarke, S.J.; Carducci, M.A.; McGuire, W.P.; Dawkins, F.; Gelderblom, H.; Verweij, J. and Sparreboom, A. (2004) Clin. Cancer Res., 10(24), 8341-8350.
117. Ball, S.E.; Scatina, J.; Kao, J.; Ferron, G.M.; Fruncillo, R.; Mayer, P.; Weinryb, I.; Guida, M.; Hopkins, P.J.; Warner, N. and Hall, J. (1999) Clin. Pharmacol. Ther., 66(3), 288-294.
118. Dai, D.; Tang, J.; Rose, R.; Hodgson, E.; Bienstock, R.J.; Mohrenweiser, H.W. and Goldstein, J.A. (2001) J. Pharmacol. Exp. Ther., 299(3), 825-831.
119. Hsieh, K.P.; Lin, Y.Y.; Cheng, C.L.; Lai, M.L.; Lin, M.S.; Siest, J.P. and Huang, J.D. (2001) Drug Metab. Dispos., 29(3), 268-273.
120. Lambs, J.K.; Lin, Y.S.; Thummel, K.; Daly, A.; Watkins, P.B.; Strom, S.; Zhang, J. and Schuetz, E.G. (2002) Pharmacogenetics, 12(2), 121-132.
121. Eiselt, R.; Domanski, T.L.; Zibat, A.; Mueller, R.; Presecan-Siedel, E.; Hustert, E.; Zanger, U.M.; Brockmoller, J.; Klenk, H.P.; Meyer, U.A.; Khan, K.K.; He, Y.A.; Halpert, J.R. and Wojnowski, L. (2001) Pharmacogenetics, 11(5), 447-458.
122. van Schaik, RH.; de Wildt, S.N.; Brosens, R.; van Fessem, M.; van den Anker, J.N. and Lindemans, J. (2001) Clin. Chem., 47(6), 1104-1106.
123. Ball, S.E.; Scatina, J.; Kao, J.; Ferron, G.M.; Fruncillo, R.; Mayer, P.; Weinryb, I.; Guida, M.; Hopkins, P.J.; Warner, N. and Hall, J. (1999) Clin. Pharmacol Ther., 66(3), 288-294.
124. Sata, F.; Sapone, A.; Elizondo, G.; Stocker, P.; Miller, V.P.; Zheng, W.; Raunio, H.; Crespi, C.L. and Gonzalez, F.J. (2000) Clin. Pharmacol. Ther., 67(1), 48-56.
125. Walker, A.H.; Jaffe, J.M.; Gunasegaram, S.; Cummings, S.A.; Huang, C.S.; Chern, H.D.; Olopade, O.I.; Weber, B.L. and Rebbeck, T.R. (1998) Hum. Mutat., 12(4), 289.
126. Fukushima-Uesaka, H.; Saito, Y.; Watanabe, H.; Shiseki, K.; Saeki, M.; Nakamura, T.; Kurose, K.; Sai, K.; Komamura, K.; Ueno, K.; Kamakura, S.; Kitakaze, M.; Hanai, S.; Nakajima, T.; Matsumoto, K.; Saito, H.; Goto, Y.; Kimura, H.; Katoh, M.; Sugai, K.; Minami, N.; Shirao, K.; Tamura, T.; Yamamoto, N.; Minami, H.; Ohtsu, A.; Yoshida, T.; Saijo, N.; Kitamura, Y.; Kamatani, N.; Ozawa, S. and Sawada, J. (2004) Hum. Mutat., 23(1), 100.
127. Kuehl, P.; Zhang, J.; Lin, Y.; Lamba, J.; Assem, M.; Schuetz, J.; Watkins, P.B.; Daly, A.; Wrighton, S.A.; Hall, S.D.; Maurel, P.; Relling, M.; Brimer, C.; Yasuda, K.; Venkataramanan, R.; Strom, S.; Thummel, K.; Boguski, M.S. and Schuetz, E. (2001) Nat. Genet., 27(4), 383-391.
128. Hustert, E.; Haberl, M.; Burk, O.; Wolbold, R.; He, Y.Q.; Klein, K.; Nuessler, A.C.; Neuhaus, P.; Klattig, J.; Eiselt, R.; Koch, I.; Zibat, A.; Brockmoller, J.; Halpert, J.R.; Zanger, U.M. and Wojnowski, L. (2001) Pharmacogenetics, 11(9), 773-779.
129. Lee, S.J.; Usmani, K.A.; Chanas, B.; Ghanayem, B.; Xi, T.; Hodgson, E.; Mohrenweiser, H.W. and Goldstein, J.A. (2003) Pharmacogenetics, 13(8), 461-472.
130. Jounaidi, Y.; Hyrailles, V.; Gervot, L. and Maurel, P. (1996) Biochem. Biophys. Res. Commun., 221(2), 466-470.
131. Chou, F.C.; Tzeng, S.J. and Huang, J.D. (2001) Drug Metab. Dispos., 29(9), 1205-1209.
132. Lee, S.J.; Usmani, K.A.; Chanas, B.; Ghanayem, B.; Xi, T.; Hodgson, E.; Mohrenweiser, H.W. and Goldstein, J.A. (2003) Pharmacogenetics, 13(8), 461-472.
133. Shimada, T.; Yamazaki, H.; Mimura, M.; Inui, Y. and Guengerich, F.P. (1994) J. Pharmacol. Exp. Ther., 270(1), 414-423.
134. Chiou, W.L.; Jeong, H.Y.; Wu, T.C. and Ma, C. (2001) Clin. Pharmacol. Ther., 70(4), 305-310.
135. Rogers, J.F.; Rocci, M.L. Jr.; Haughey, D.B. and Bertino, J.S. Jr. (2003) Clin. Pharmacol. Ther., 73(3), 153-158.
136. Thummel, K.E.; Shen, D.D.; Podoll, T.D.; Kunze, K.L.; Trager, W.F.; Hartwell, P.S.; Raisys, V.A.; Marsh, C.L.; McVicar, J.P. and Barr, D.M. (1994) J. Pharmacol. Exp. Ther., 271(1), 549-556.
137. Thummel, K.E.; O'Shea, D.; Paine, M.F.; Shen, D.D.; Kunze, K.L.; Perkins, J.D. and Wilkinson, G.R. (1996) Clin. Pharmacol. Ther., 59(5), 491-502.
138. Watkins, P.B.; Turgeon, D.K.; Saenger, P.; Lown, K.S.; Kolars, J.C.; Hamilton, T.; Fishman, K.; Guzelian, P.S. and Voorhees, J.J. (1992) Clin. Pharmacol. Ther., 52(3), 265-273.
139. Marre, F.; Sanderink, G.J.; de Sousa, G.; Gaillard, C.; Martinet, M. and Rahmani, R. (1996) Cancer Res., 56(6), 1296-1302.
140. Shou, M.; Martinet, M.; Korzekwa, K.R.; Krausz, K.W.; Gonzalez, F.J. and Gelboin, H.V. (1998) Pharmacogenetics, 8(5), 391-401.
141. Kamatani, T.; Yokoi, T.; Fujita, K. and Ando, Y. (1998) Cancer Chemother. Pharmacol., 42(Suppl), S50-S53.
142. Hirth, J.; Watkins, P.B.; Strawderman, M.; Schott, A.; Bruno, R. and Baker, L.H (2000) Clin. Cancer Res., 6(4), 1255-1258.
143. Yamamoto, N.; Tamura, T.; Kamiya, Y.; Sekine, I.; Kunitoh, H. and Saijo, N. (2000) J. Clin. Oncol., 18(11), 2301-2308.
144. Yamamoto, N.; Tamura, T.; Murakami, H.; Shimoyama, T.; Nokihara, H.; Ueda, Y.; Sekine, I.; Kunitoh, H.; Ohe, Y.; Kodam, T.; Shimizu, M.; Nishio, K.; Ishizuka, N. and Saijo, N. (2005) J. Clin. Oncol., 23(6), 1061-1069.
145. Goh, B.C.; Lee, S.C.; Wang, L.Z.; Fan, L.; Guo, J.Y.; Lamba, J.; Schuetz, E.; Lim, R.; Lim, H.L.; Ong, A.B. and Lee, H.S. (2002) J. Clin. Oncol., 20(17), 3683-3690.
146. Rougier, P.; Van Cutsem, E.; Bajetta, E.; Niederle, N.; Possinger, K.; Labianca, R.; Navarro, M.; Morant, R.; Bleiberg, H.; Wils, J.; Awad, L.; Herait, P. and Jacques, C. (1998) Lancet, 352(9138), 1407-1412.
147. Kudoh, S.; Fujiwara, Y.; Takada, Y.; Yamamoto, H.; Kinoshita, A.; Ariyoshi, Y.; Furuse, K. and Fukuoka, M. (1998) J. Clin. Oncol., 16(3), 1068-1074.
148. Negoro, S.; Fukuoka, M.; Masuda, N.; Takada, M.; Kusunoki, Y.; Matsui, K.; Takifuji, N.; Kudoh, S.; Niitani, H. and Taguchi, T. (1991) J. Natl. Cancer Inst., 83(16), 1164-1168.
149. Mathijssen, R.H.; van Alphen, R.J.; Verweij, J.; Loos, W.J.; Nooter, K.; Stoter, G. and Sparreboom, A. (2001) Clin. Cancer Res., 7(8), 2182-2194.
150. Santos, A.; Zanetta, S.; Cresteil, T.; Deroussent, A.; Pein, F.; Raymond, E.; Vernillet, L.; Risse, M.L.; Boige, V.; Gouyette, A. and Vassal, G. (2000) Clin. Cancer Res., 6(5), 2012-2020.
151. Mathijssen, R.H.; de Jong, F.A.; van Schaik, R.H.; Lepper, E.R.; Friberg, L.E.; Rietveld, T.; de Bruijn, P.; Graveland, W.J.; Figg, W.D.; Verweij, J. and Sparreboom, A. (2004) J. Natl. Cancer Inst., 96(21), 1585-1592.
152. Honig, P.K.; Wortham, D.C.; Zamani, K.; Conner, D.P.; Mullin, J.C. and Cantilena, L.R. (1993) JAMA, 269(12), 1513-1518.
153. Malingre, M.M.; Richel, D.J.; Beijnen, J.H.; Rosing, H.; Koopman, F.J.; Ten Bokkel Huinink, W.W.; Schot, M.E. and Schellens, J.H. (2001) J. Clin. Oncol., 19(4), 1160-1166.
154. O'Brien, S.G.; Meinhardt, P.; Bond, E.; Beck, J.; Peng, B.; Dutreix, C.; Mehring, G.; Milosavljev, S.; Huber, C.; Capdeville, R. and Fischer, T. (2003) Br. J. Cancer, 89(10), 1855-1859.
155. Dutreix, C.; Peng, B.; Mehring, G.; Hayes, M.; Capdeville, R.; Pokorny, R. and Seiberling, M. (2004) Cancer Chemother. Pharmacol., 54(4), 290-294.
156. Frye, R.F.; Fitzgerald, S.M.; Lagattuta, T.F.; Hruska, M.W. and Egorin, M.J. (2004) Clin. Pharmacol. Ther., 76(4), 323-329.
157. Smith, P.F.; Bullock, J.M.; Booker, B.M.; Haas, C.E.; Berenson, C.S. and Jusko, W.J. (2004) Blood, 104(4), 1229-1230.
158. Bolton, A.E.; Peng, B.; Hubert, M.; Krebs-Brown, A.; Capdeville, R.; Keller, U. and Seiberling, M. (2004) Cancer Chemother. Pharmacol., 53(2), 102-106.
159. Chang, S.M.; Kuhn, J.G.; Rizzo, J.; Robins, H.I.; Schold, S.C. Jr; Spence, A.M.; Berger, M.S.; Mehta, M.P.; Bozik, M.E.; Pollack, I.; Gilbert, M.; Fulton, D.; Rankin, C.; Malec, M. and Prados, M.D. (1998) J. Clin. Oncol., 16(6), 2188-2194.
160. Chang, S.M.; Kuhn, J.G.; Robins, H.I.; Schold, S.C. Jr.; Spence, A.M.; Berger, M.S.; Mehta, M.; Pollack, I.F.; Rankin, C. and Prados, M.D. (2001) Cancer, 91(2), 417-422.
161. Rahmani, R.; Kleisbauer, J.P.; Cano, J.P.; Martin, M. and Barber, J. (1985) Cancer Treat. Rep., 69(7-8), 839-844.
162. Rahmani, R.; Martin, M.; Favre, R.; Cano, J.P. and Barbet J. (1984) Eur. J. Cancer Clin. Oncol., 20(11), 1409-1417.
163. Zhou, X.J. and Rahmani, R. (1992) Drugs, 44(Suppl 4), 1-16.
164. Villikka, K.; Kivisto, K.T.; Maenpaa, H.; Joensuu, H. and Neuvonen, P.J. (1999) Clin. Pharmacol. Ther., 66(6), 589-593.
165. Oyama, T.; Morita, M.; Isse, T.; Kagawa, N.; Nakata, S.; So, T.; Mizukami, M.; Ichiki, Y.; Ono, K.; Sugaya, M.; Uramoto, H.; Yoshimatsu, T.; Hanagiri, T.; Sugio, K.; Kawamoto, T. and Yasumoto, K. (2005) Front. Biosci., 10, 1156-1161.
166. El-Rayes, B.F.; Ali, S.; Heilbrun, L.K.; Lababidi, S.; Bouwman, D.; Visscher, D. and Philip, P.A. (2003) Clin. Cancer Res., 9(5), 1705-1709.
167. Iscan, M.; Klaavuniemi, T.; Coban, T.; Kapucuoglu, N.; Pelkonen, O. and Raunio, H. (2001) Breast Cancer Res. Treat., 70(1), 47-54.
168. Yokose, T.; Doy, M.; Taniguchi, T.; Shimada, T.; Kakiki, M.; Horie, T.; Matsuzaki, Y. and Mukai, K. (1999) Virchows. Arch., 434(5), 401-411.
169. Murray, G.I.; Taylor, V.E.; McKay, J.A.; Weaver, R.J.; Ewen, S.W.; Melvin, W.T. and Burke, M.D. (1995) J. Pathol., 177(2), 147-152.
170. Murray, G.I.; Weaver, R.J.; Paterson, P.J.; Ewen, S.W.; Melvin, W.T. and Burke, M.D. (1993) J. Pathol., 169(3), 347-353.
171. Murray, G.I.; Shaw, D.; Weaver, R.J.; McKay, J.A.; Ewen, S.W.; Melvin, W.T. and Burke, M.D. (1994) Gut, 35(5), 599-603.
172. McKay, J.A.; Murray, G.I.; Weaver, R.J.; Ewen, S.W.; Melvin, W.T. and Burke, M.D. (1993) Gut, 34(9), 1234-1239.
173. Miyoshi, Y.; Ando, A.; Takamura, Y.; Taguchi, T.; Tamaki, Y. and Noguchi, S. (2002) Int. J. Cancer, 97(1), 129-132.
174. Jounaidi, Y.; Hecht, J.E. and Waxman, D.J. (1998) Cancer Res., 58(19), 4391-401.
175. Jounaidi, Y. and Waxman, D.J. (2004) Cancer Res., 64(1), 292-303.